Christopher Pierce's Insider Trades & SAST Disclosures

Christopher Pierce's most recent trade in Mechanics Bancorp. - Ordinary Shares - Class A was a trade of 7,626 Class A Common Stock done . Disclosure was reported to the exchange on March 1, 2026.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Mechanics Bancorp. (Class A)
Christopher D Pierce EVP & Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2026 7,626 38,496 - - Class A Common Stock
Mechanics Bancorp. (Class A)
Christopher D Pierce EVP & Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2026 4,580 9,162 - - Incentive Units - Not Deferred (2024)
Mechanics Bancorp. (Class A)
Christopher D Pierce EVP & Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2026 4,580 32,757 - - Class A Common Stock
Mechanics Bancorp. (Class A)
Christopher D Pierce EVP & Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.37 per share. 15 Feb 2026 1,887 30,870 - 15.4 29,003 Class A Common Stock
Mechanics Bancorp. (Class A)
Christopher D Pierce EVP & Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2025 21,818 33,080 - 0 Class A Common Stock
Mechanics Bancorp. (Class A)
Christopher D Pierce EVP & Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2025 13,742 13,742 - - Incentive Units - Not Deferred (2024)
Mechanics Bancorp. (Class A)
Christopher D Pierce EVP & Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2025 11,262 11,262 - - Class A Common Stock
Mechanics Bancorp. (Class A)
Christopher D Pierce EVP & Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.63 per share. 02 Sep 2025 4,903 28,177 - 14.6 71,731 Class A Common Stock
Prelude Therapeutics Inc
Christopher Pierce EVP and Chief of Business Oper Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Sep 2021 17,000 207,796 - - Employee Stock Option (right to buy)
Prelude Therapeutics Inc
Christopher Pierce EVP and Chief of Business Oper Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.85 per share. 02 Sep 2021 17,000 20,750 - 12.9 218,450 Common Stock
Prelude Therapeutics Inc
Christopher Pierce EVP and Chief of Business Oper Sale of securities on an exchange or to another person at price $ 42.50 per share. 02 Sep 2021 6,930 3,750 - 42.5 294,507 Common Stock
Prelude Therapeutics Inc
Christopher Pierce EVP and Chief of Business Oper Sale of securities on an exchange or to another person at price $ 41.52 per share. 02 Sep 2021 6,727 10,680 - 41.5 279,289 Common Stock
Prelude Therapeutics Inc
Christopher Pierce EVP and Chief of Business Oper Sale of securities on an exchange or to another person at price $ 40.29 per share. 02 Sep 2021 3,343 17,407 - 40.3 134,697 Common Stock
Prelude Therapeutics Inc
Christopher Pierce EVP and Chief of Business Oper Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2021 85,000 85,000 - - Employee Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades